JP2002539204A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2002539204A5 JP2002539204A5 JP2000605578A JP2000605578A JP2002539204A5 JP 2002539204 A5 JP2002539204 A5 JP 2002539204A5 JP 2000605578 A JP2000605578 A JP 2000605578A JP 2000605578 A JP2000605578 A JP 2000605578A JP 2002539204 A5 JP2002539204 A5 JP 2002539204A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- compound
- composition according
- compound according
- nhco
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 description 14
- 239000000203 mixture Substances 0.000 description 11
- 125000002252 acyl group Chemical group 0.000 description 5
- 125000006367 bivalent amino carbonyl group Chemical group [H]N([*:1])C([*:2])=O 0.000 description 5
- 125000006297 carbonyl amino group Chemical group [H]N([*:2])C([*:1])=O 0.000 description 5
- 150000002825 nitriles Chemical class 0.000 description 5
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 4
- 125000004453 alkoxycarbonyl group Chemical group 0.000 description 4
- 125000000217 alkyl group Chemical group 0.000 description 4
- 125000003277 amino group Chemical group 0.000 description 4
- 125000002795 guanidino group Chemical group C(N)(=N)N* 0.000 description 4
- 125000002768 hydroxyalkyl group Chemical group 0.000 description 4
- 229910052760 oxygen Inorganic materials 0.000 description 4
- 239000002202 Polyethylene glycol Chemical group 0.000 description 3
- 239000003443 antiviral agent Substances 0.000 description 3
- 125000001183 hydrocarbyl group Chemical group 0.000 description 3
- 208000015181 infectious disease Diseases 0.000 description 3
- 229920001223 polyethylene glycol Chemical group 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 241000124008 Mammalia Species 0.000 description 2
- 208000036142 Viral infection Diseases 0.000 description 2
- 108090000765 processed proteins & peptides Chemical group 0.000 description 2
- 230000009385 viral infection Effects 0.000 description 2
- UBCHPRBFMUDMNC-UHFFFAOYSA-N 1-(1-adamantyl)ethanamine Chemical compound C1C(C2)CC3CC2CC1(C(N)C)C3 UBCHPRBFMUDMNC-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- IWUCXVSUMQZMFG-AFCXAGJDSA-N Ribavirin Chemical compound N1=C(C(=O)N)N=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](CO)O1 IWUCXVSUMQZMFG-AFCXAGJDSA-N 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
- 125000003545 alkoxy group Chemical group 0.000 description 1
- 125000003282 alkyl amino group Chemical group 0.000 description 1
- DKNWSYNQZKUICI-UHFFFAOYSA-N amantadine Chemical compound C1C(C2)CC3CC2CC1(N)C3 DKNWSYNQZKUICI-UHFFFAOYSA-N 0.000 description 1
- 229960003805 amantadine Drugs 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 125000000852 azido group Chemical group *N=[N+]=[N-] 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 125000003827 glycol group Chemical group 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 208000037797 influenza A Diseases 0.000 description 1
- 208000037798 influenza B Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- -1 methoxy, hydroxy Chemical group 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 229920001542 oligosaccharide Chemical group 0.000 description 1
- 150000002482 oligosaccharides Chemical group 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 229920001308 poly(aminoacid) Chemical group 0.000 description 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- 229960000329 ribavirin Drugs 0.000 description 1
- HZCAHMRRMINHDJ-DBRKOABJSA-N ribavirin Natural products O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1N1N=CN=C1 HZCAHMRRMINHDJ-DBRKOABJSA-N 0.000 description 1
- 229960000888 rimantadine Drugs 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- SQVRNKJHWKZAKO-OQPLDHBCSA-N sialic acid Chemical class CC(=O)N[C@@H]1[C@@H](O)C[C@@](O)(C(O)=O)OC1[C@H](O)[C@H](O)CO SQVRNKJHWKZAKO-OQPLDHBCSA-N 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 125000004044 trifluoroacetyl group Chemical group FC(C(=O)*)(F)F 0.000 description 1
- 241000712461 unidentified influenza virus Species 0.000 description 1
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AUPP9139A AUPP913999A0 (en) | 1999-03-12 | 1999-03-12 | Novel chemical compounds and their use |
| AUPP9139 | 1999-03-12 | ||
| AU9139 | 1999-03-12 | ||
| PCT/AU2000/000165 WO2000055149A1 (en) | 1999-03-12 | 2000-03-09 | Dimeric compounds and as inhibitors of neuraminidase |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2002539204A JP2002539204A (ja) | 2002-11-19 |
| JP2002539204A5 true JP2002539204A5 (https=) | 2007-04-19 |
| JP5160000B2 JP5160000B2 (ja) | 2013-03-13 |
Family
ID=3813338
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000605578A Expired - Fee Related JP5160000B2 (ja) | 1999-03-12 | 2000-03-09 | 二量体化合物およびニューラミニダーゼ阻害剤として |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US6548476B1 (https=) |
| EP (1) | EP1165541B1 (https=) |
| JP (1) | JP5160000B2 (https=) |
| KR (1) | KR100805906B1 (https=) |
| CN (1) | CN1343205A (https=) |
| AP (1) | AP2001002277A0 (https=) |
| AT (1) | ATE295361T1 (https=) |
| AU (2) | AUPP913999A0 (https=) |
| BR (1) | BR0008939A (https=) |
| CA (1) | CA2367755C (https=) |
| CZ (1) | CZ20013274A3 (https=) |
| DE (1) | DE60020100T2 (https=) |
| EA (1) | EA200100968A1 (https=) |
| ES (1) | ES2241581T3 (https=) |
| HK (1) | HK1041693B (https=) |
| HU (1) | HUP0200190A3 (https=) |
| ID (1) | ID29868A (https=) |
| IL (1) | IL145346A (https=) |
| MX (1) | MXPA01009203A (https=) |
| NO (1) | NO327812B1 (https=) |
| NZ (1) | NZ514041A (https=) |
| PL (1) | PL350228A1 (https=) |
| TR (1) | TR200102794T2 (https=) |
| TW (1) | TWI268279B (https=) |
| WO (1) | WO2000055149A1 (https=) |
| ZA (1) | ZA200107450B (https=) |
Families Citing this family (64)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ335368A (en) * | 1996-11-14 | 2001-08-31 | Biota Scient Management | Macromolecular compound with one or more neuraminidase binders, binds to the active site of influenza virus neuraminidase |
| DE19930177B4 (de) * | 1999-06-30 | 2007-02-08 | Nikolai Vladimirovich Bovin | Intermolekular assoziierende Verbindungen und deren Verwendung |
| AUPQ288499A0 (en) | 1999-09-16 | 1999-10-07 | Biota Scientific Management Pty Ltd | Antiviral agents |
| AUPR001000A0 (en) * | 2000-09-08 | 2000-10-05 | Biota Scientific Management Pty Ltd | Novel chemical compounds and their use |
| AU2002340635B2 (en) * | 2001-11-09 | 2008-03-13 | Biota Scientific Management Pty Ltd | Dimeric compounds and their use as anti-viral agents |
| AUPR879501A0 (en) | 2001-11-09 | 2001-12-06 | Biota Scientific Management Pty Ltd | Novel chemical compounds and their use |
| AU2002340632B2 (en) * | 2001-11-09 | 2008-03-20 | Biota Scientific Management Pty Ltd | Dimeric compounds and their use as anti-viral agents |
| AUPR879601A0 (en) * | 2001-11-09 | 2001-12-06 | Biota Scientific Management Pty Ltd | Novel chemical compounds and their use |
| AUPR879401A0 (en) * | 2001-11-09 | 2001-12-06 | Biota Scientific Management Pty Ltd | Novel chemical compounds and their use |
| AU2002336823B2 (en) * | 2001-11-09 | 2008-03-20 | Biota Scientific Management Pty Ltd | Dimeric compounds and their use as anti-viral agents |
| CN1285591C (zh) | 2001-11-09 | 2006-11-22 | 百奥塔科学管理有限公司 | 二聚化合物及其作为抗病毒剂的应用 |
| AUPR879701A0 (en) * | 2001-11-09 | 2001-12-06 | Biota Scientific Management Pty Ltd | Novel chemical compounds and their use |
| BRPI0314042B8 (pt) * | 2002-09-06 | 2021-05-25 | Calando Pharmaceuticals Inc | polímeros à base de ciclodextrina para o fornecimento de agentes terapêuticos ligados a eles por covalência |
| US7317122B2 (en) | 2004-12-04 | 2008-01-08 | Xerox Corporation | Curable trans-1,2-cyclohexane bis(urea-urethane) compounds |
| US7560587B2 (en) * | 2004-12-04 | 2009-07-14 | Xerox Corporation | Bis[urea-urethane] compounds |
| US7314949B2 (en) | 2004-12-04 | 2008-01-01 | Xerox Corporation | Trans-1,2-cyclohexane bis(urea-urethane) compounds |
| US7144450B2 (en) * | 2004-12-04 | 2006-12-05 | Xerox Corporation | Phase change inks containing trans-1,2-cyclohexane bis(urea-urethane) compounds |
| US7576235B2 (en) | 2004-12-04 | 2009-08-18 | Xerox Corporation | Processes for preparing bis(urea-urethane) compounds |
| US7153349B2 (en) | 2004-12-04 | 2006-12-26 | Xerox Corporation | Phase change inks containing curable trans-1,2-cyclohexane bis(urea-urethane) compounds |
| US7220300B2 (en) | 2004-12-04 | 2007-05-22 | Xerox Corporation | Phase change inks containing bis(urea-urethane) compounds |
| US8227425B2 (en) * | 2007-01-23 | 2012-07-24 | Therapicon Srl | Antiviral compounds |
| US20080176958A1 (en) | 2007-01-24 | 2008-07-24 | Insert Therapeutics, Inc. | Cyclodextrin-based polymers for therapeutics delivery |
| US7960139B2 (en) | 2007-03-23 | 2011-06-14 | Academia Sinica | Alkynyl sugar analogs for the labeling and visualization of glycoconjugates in cells |
| CA2692419C (en) | 2007-07-03 | 2017-12-05 | Children's Hospital & Research Center At Oakland | Inhibitors of polysialic acid de-n-acetylase and methods for using the same |
| EP2173759A4 (en) | 2007-07-03 | 2014-01-29 | Childrens Hosp & Res Ct Oak | OLIGOSIAL INSERTS, PROCESS FOR THEIR PREPARATION AND ITS IMMUNOLOGICAL USE |
| JP5523313B2 (ja) | 2007-07-03 | 2014-06-18 | チルドレンズ ホスピタル アンド リサーチ センター アット オークランド | ポリシアル酸誘導体、製造方法、ならびにがん抗原産生の増強およびターゲティングにおける使用 |
| JP5986745B2 (ja) | 2008-07-15 | 2016-09-06 | アカデミア シニカＡｃａｄｅｍｉａ Ｓｉｎｉｃａ | Ｐｔｆｅ様のアルミニウム・コート・ガラススライド上のグリカンアレイおよび関連する方法 |
| US20110160159A1 (en) * | 2009-09-15 | 2011-06-30 | John Ryan | Treatment of cancer |
| NL2005389A (en) | 2009-10-21 | 2011-04-26 | Asml Netherlands Bv | Lithographic apparatus, device manufacturing method, and method of applying a pattern to a substrate. |
| IT1396620B1 (it) * | 2009-11-25 | 2012-12-14 | Therapicon Srl | Analoghi chimerici |
| US11377485B2 (en) | 2009-12-02 | 2022-07-05 | Academia Sinica | Methods for modifying human antibodies by glycan engineering |
| US10087236B2 (en) | 2009-12-02 | 2018-10-02 | Academia Sinica | Methods for modifying human antibodies by glycan engineering |
| US10338069B2 (en) | 2010-04-12 | 2019-07-02 | Academia Sinica | Glycan arrays for high throughput screening of viruses |
| NZ607000A (en) * | 2010-08-24 | 2015-02-27 | Imp Innovations Ltd | Glycodendrimers of polypropyletherimine |
| CN104080450A (zh) * | 2012-01-05 | 2014-10-01 | 阿拉维制药公司 | 扎那米韦生物利用度增强的制剂 |
| US10130714B2 (en) | 2012-04-14 | 2018-11-20 | Academia Sinica | Enhanced anti-influenza agents conjugated with anti-inflammatory activity |
| WO2014031498A1 (en) | 2012-08-18 | 2014-02-27 | Academia Sinica | Cell-permeable probes for identification and imaging of sialidases |
| WO2014055493A1 (en) | 2012-10-02 | 2014-04-10 | Cerulean Pharma Inc. | Methods and systems for polymer precipitation and generation of particles |
| EP3013365B1 (en) | 2013-06-26 | 2019-06-05 | Academia Sinica | Rm2 antigens and use thereof |
| WO2014210564A1 (en) | 2013-06-27 | 2014-12-31 | Academia Sinica | Glycan conjugates and use thereof |
| US9782476B2 (en) | 2013-09-06 | 2017-10-10 | Academia Sinica | Human iNKT cell activation using glycolipids with altered glycosyl groups |
| US10150818B2 (en) | 2014-01-16 | 2018-12-11 | Academia Sinica | Compositions and methods for treatment and detection of cancers |
| CA2937123A1 (en) | 2014-01-16 | 2015-07-23 | Academia Sinica | Compositions and methods for treatment and detection of cancers |
| WO2015148915A1 (en) | 2014-03-27 | 2015-10-01 | Academia Sinica | Reactive labelling compounds and uses thereof |
| CA2950423A1 (en) | 2014-05-27 | 2015-12-03 | Academia Sinica | Compositions and methods relating to universal glycoforms for enhanced antibody efficacy |
| KR102512592B1 (ko) | 2014-05-27 | 2023-03-21 | 아카데미아 시니카 | 항-ｈｅｒ2 글리코항체 및 이의 용도 |
| KR20170003720A (ko) | 2014-05-27 | 2017-01-09 | 아카데미아 시니카 | 항-ｃｄ20 글리코항체 및 이의 용도 |
| US10118969B2 (en) | 2014-05-27 | 2018-11-06 | Academia Sinica | Compositions and methods relating to universal glycoforms for enhanced antibody efficacy |
| CN106714829A (zh) | 2014-05-28 | 2017-05-24 | 中央研究院 | 抗TNF‑α醣抗体及其用途 |
| CA2960712A1 (en) | 2014-09-08 | 2016-03-17 | Academia Sinica | Human inkt cell activation using glycolipids |
| US9975965B2 (en) | 2015-01-16 | 2018-05-22 | Academia Sinica | Compositions and methods for treatment and detection of cancers |
| US10495645B2 (en) | 2015-01-16 | 2019-12-03 | Academia Sinica | Cancer markers and methods of use thereof |
| AU2015378564A1 (en) | 2015-01-24 | 2017-07-13 | Academia Sinica | Novel glycan conjugates and methods of use thereof |
| ES2911027T3 (es) * | 2015-11-20 | 2022-05-17 | AusVir Therapeutics Pty Ltd | Compuestos para aplicaciones medicinales |
| RU2612221C1 (ru) * | 2015-12-16 | 2017-03-03 | Общество с ограниченной ответственностью "Синтавр" | Блокаторы вируса гриппа |
| WO2017156192A1 (en) | 2016-03-08 | 2017-09-14 | Academia Sinica | Methods for modular synthesis of n-glycans and arrays thereof |
| EP3500594A4 (en) | 2016-08-22 | 2020-03-11 | Cho Pharma Inc. | ANTIBODIES, BINDING FRAGMENTS AND METHOD FOR USE |
| CN108003065B (zh) * | 2016-10-27 | 2021-01-08 | 中国石油化工股份有限公司 | 一种具有增稠作用的化合物和润滑脂以及它们的制备方法 |
| WO2018199798A1 (ru) * | 2017-04-28 | 2018-11-01 | Общество с ограниченной ответственностью "Синтавр" | Пептидные производные противовирусного препарата занамивира |
| US11773129B2 (en) * | 2017-05-25 | 2023-10-03 | The Governors Of The University Of Alberta | Methods of preventing or treating atherosclerosis with inhibitors of specific isoenzymes of human neuraminidase |
| CN111698999A (zh) * | 2017-12-06 | 2020-09-22 | 阿道恰公司 | 包含至少一种pi在5.8与8.5之间的基础胰岛素和带有羧酸根电荷及疏水基的共聚氨基酸的ph为7的可注射溶液 |
| KR20210079278A (ko) * | 2018-09-06 | 2021-06-29 | 시다라 세라퓨틱스, 인코포레이티드 | 바이러스 감염의 치료를 위한 조성물 및 방법 |
| BR112021006403A2 (pt) * | 2018-10-05 | 2021-07-06 | Univ Emory | agentes monômeros e multiméricos anti-hbv |
| TWI861205B (zh) | 2019-09-06 | 2024-11-11 | 美商席達拉醫療有限公司 | 用於治療病毒感染之組合物及方法 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2050484A1 (en) * | 1990-02-27 | 1991-08-28 | Satoru Nakabayashi | Sialic acid-containing glycolipid derivatives |
| ATE193551T1 (de) * | 1991-03-18 | 2000-06-15 | Scripps Research Inst | Oligosaccharide als enzymsubstrate und - inhibitoren: verfahren und zusammensetzungen |
| CA2129987A1 (en) * | 1992-02-19 | 1993-09-02 | Naoya Kojima | Inhibition of cell adhesion by chemically-defined oligosaccharides, their derivatives, mimetics, and antibodies directed thereto |
| JPH0638784A (ja) * | 1992-03-30 | 1994-02-15 | Meiji Milk Prod Co Ltd | シアル酸を構成要素とする糖鎖の製造方法 |
| ZA937034B (en) * | 1992-09-24 | 1995-06-23 | Brigham & Womens Hospital | Group B streptococcus type II and type V polysaccharide-protein conjugate vaccines |
| US5658880A (en) * | 1993-06-16 | 1997-08-19 | Glycomed Incorporated | Sialic acid/fucose based medicaments |
| US5837689A (en) * | 1993-06-16 | 1998-11-17 | Glycomed Incorporated | Sialyl lewis-x mimetics containing naphthyl backbones |
| BR9607098B8 (pt) * | 1995-02-27 | 2014-11-18 | Gilead Sciences Inc | Composto e composição farmacêutica. |
| US5780606A (en) * | 1995-06-07 | 1998-07-14 | Connaught Laboratories Limited | Neisseria meningitidis capsular polysaccharide conjugates |
| CA2245680C (en) | 1996-03-01 | 2005-09-27 | Biota Scientific Management Pty. Ltd. | Method of detection of influenza virus and compounds for use therein |
| US5891862A (en) * | 1996-03-15 | 1999-04-06 | Geltex Pharmaceuticals, Inc. | Polyvalent polymers for the treatment of rotavirus infection |
| AUPO104396A0 (en) | 1996-07-17 | 1996-08-08 | Biomolecular Research Institute Limited | Antiviral linear polymers |
| JP4179567B2 (ja) * | 1996-07-23 | 2008-11-12 | 生化学工業株式会社 | 新規ラクトサミンオリゴ糖およびその製造方法 |
| NZ335368A (en) | 1996-11-14 | 2001-08-31 | Biota Scient Management | Macromolecular compound with one or more neuraminidase binders, binds to the active site of influenza virus neuraminidase |
| JPH10182686A (ja) * | 1996-12-26 | 1998-07-07 | Ngk Insulators Ltd | ガングリオシドＧＱ１ｂ類縁物質 |
| WO1998046279A1 (fr) | 1997-04-17 | 1998-10-22 | Johnson & Johnson Medical Kabushiki Kaisha | Feuilles indicateurs chimiques et poches pour sterilisation utilisant lesdites feuilles |
| WO1999063929A2 (en) | 1998-06-08 | 1999-12-16 | Advanced Medicine, Inc. | Multibinding inhibitors of microsomal triglyceride transferase protein |
-
1999
- 1999-03-12 AU AUPP9139A patent/AUPP913999A0/en not_active Abandoned
-
2000
- 2000-03-09 AT AT00907354T patent/ATE295361T1/de not_active IP Right Cessation
- 2000-03-09 IL IL14534600A patent/IL145346A/xx not_active IP Right Cessation
- 2000-03-09 JP JP2000605578A patent/JP5160000B2/ja not_active Expired - Fee Related
- 2000-03-09 ES ES00907354T patent/ES2241581T3/es not_active Expired - Lifetime
- 2000-03-09 PL PL00350228A patent/PL350228A1/xx unknown
- 2000-03-09 EA EA200100968A patent/EA200100968A1/ru unknown
- 2000-03-09 EP EP00907354A patent/EP1165541B1/en not_active Expired - Lifetime
- 2000-03-09 KR KR1020017011546A patent/KR100805906B1/ko not_active Expired - Fee Related
- 2000-03-09 ID IDW00200101979A patent/ID29868A/id unknown
- 2000-03-09 AU AU28966/00A patent/AU774222B2/en not_active Ceased
- 2000-03-09 TR TR2001/02794T patent/TR200102794T2/xx unknown
- 2000-03-09 CN CN00804901A patent/CN1343205A/zh active Pending
- 2000-03-09 AP APAP/P/2001/002277A patent/AP2001002277A0/en unknown
- 2000-03-09 HK HK02103316.9A patent/HK1041693B/en not_active IP Right Cessation
- 2000-03-09 DE DE60020100T patent/DE60020100T2/de not_active Expired - Lifetime
- 2000-03-09 WO PCT/AU2000/000165 patent/WO2000055149A1/en not_active Ceased
- 2000-03-09 HU HU0200190A patent/HUP0200190A3/hu unknown
- 2000-03-09 CZ CZ20013274A patent/CZ20013274A3/cs unknown
- 2000-03-09 MX MXPA01009203A patent/MXPA01009203A/es active IP Right Grant
- 2000-03-09 NZ NZ514041A patent/NZ514041A/xx not_active Application Discontinuation
- 2000-03-09 CA CA002367755A patent/CA2367755C/en not_active Expired - Fee Related
- 2000-03-09 BR BR0008939-7A patent/BR0008939A/pt not_active IP Right Cessation
- 2000-09-08 US US09/658,445 patent/US6548476B1/en not_active Expired - Lifetime
- 2000-09-08 TW TW089118492A patent/TWI268279B/zh not_active IP Right Cessation
-
2001
- 2001-09-10 ZA ZA200107450A patent/ZA200107450B/xx unknown
- 2001-09-11 NO NO20014409A patent/NO327812B1/no not_active IP Right Cessation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2002539204A5 (https=) | ||
| JP5160000B2 (ja) | 二量体化合物およびニューラミニダーゼ阻害剤として | |
| JP2004507564A5 (https=) | ||
| CA2376978A1 (en) | Compositions and methods for treatment of sexual dysfunction | |
| JP2006527185A5 (https=) | ||
| US6740635B2 (en) | Antiviral linear polymers | |
| RU2003127395A (ru) | Содержащие пэг конъюгаты hgf-nk4 | |
| JP5465182B2 (ja) | ポリアルキレンイミンを含むウイルス感染症治療薬 | |
| CN102775458A (zh) | β-D-(2’R)-2’-脱氧—2’-氟-2’-C-甲基胞苷衍生物的制备及用途 | |
| KR890006228A (ko) | 항종양제로서 폴리아민 유도체 | |
| CA2463835A1 (en) | Dimeric compounds and their use as anti-viral agents | |
| US20230263900A1 (en) | Dendrimer-drug conjugate | |
| CA2462337A1 (en) | Dimeric compounds and their use as anti-viral agents | |
| JP2006515629A (ja) | 吸収促進剤 | |
| US20100267616A1 (en) | Acute respiratory syndromes | |
| JP2025505673A (ja) | Ｃｏｖｉｄ感染症を処置するための方法および組成物 | |
| US20070036744A1 (en) | Treatment or prevention of respiratory viral infections with alpha thymosin peptides | |
| EP1748783A4 (en) | TREATMENT OR PREVENTION OF RESPIRATORY VIRAL INFECTIONS USING IMMUNOMODULATORY COMPOUNDS | |
| CN116367843A (zh) | 病毒抑制剂 | |
| JP2011016804A5 (https=) | ||
| CA2462345A1 (en) | Dimeric compounds and their use as anti-viral agents | |
| JPWO2004083186A1 (ja) | ウイルス性肝炎治療剤及び制癌剤 | |
| CA2463865A1 (en) | Dimeric compounds and their use as anti-viral agents | |
| JPWO2017086235A1 (ja) | マクロライド系免疫抑制剤の高分子誘導体 | |
| Asmar et al. | Antiviral therapy: Respiratory infections, chornic hepatitis |